• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Canopy Growth Corporation (Amendment)

    4/19/24 5:00:49 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $CGC alert in real time by email
    SC 13D/A 1 d823440dsc13da.htm SC 13D/A SC 13D/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 13)

     

     

    Canopy Growth Corporation

    (Name of Issuer)

    Common Shares, no par value

    (Title of Class of Securities)

    901164

    (CUSIP Number)

    Lloyd H. Spencer, Esq.

    Nixon Peabody LLP

    799 9th Street NW, Suite 500

    Washington, D.C. 20001

    (202) 585-8000

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    April 18, 2024

    (Date of Event which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ☐.

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    Page 2

    SCHEDULE 13D

    CUSIP No. 901164

     

     1   

     NAME OF REPORTING PERSONS

     

     Greenstar Canada Investment Limited Partnership

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☒  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS

     

     OO

     5  

     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     British Columbia

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7    

     SOLE VOTING POWER

     

     0

        8   

     SHARED VOTING POWER

     

     15,811,474

        9   

     SOLE DISPOSITIVE POWER

     

     0

       10   

     SHARED DISPOSITIVE POWER

     

     15,811,474

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     15,811,474

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

     ☒

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     15.8%

    14  

     TYPE OF REPORTING PERSON

     

     PN


    Page 3

    SCHEDULE 13D

    CUSIP No. 901164

     

     1   

     NAME OF REPORTING PERSONS

     

     Greenstar Canada Investment Corporation

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☒  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS

     

     OO

     5  

     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     British Columbia

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7    

     SOLE VOTING POWER

     

     0

        8   

     SHARED VOTING POWER

     

     15,811,474

        9   

     SOLE DISPOSITIVE POWER

     

     0

       10   

     SHARED DISPOSITIVE POWER

     

     15,811,474

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     15,811,474

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

     ☒

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     15.8%

    14  

     TYPE OF REPORTING PERSON

     

     CO


    Page 4

    SCHEDULE 13D

    CUSIP No. 901164

     

     1   

     NAME OF REPORTING PERSONS

     

     Constellation Brands Canada Holdings ULC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☒  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS

     

     OO

     5  

     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Nova Scotia

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7    

     SOLE VOTING POWER

     

     0

        8   

     SHARED VOTING POWER

     

     15,811,474

        9   

     SOLE DISPOSITIVE POWER

     

     0

       10   

     SHARED DISPOSITIVE POWER

     

     15,811,474

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     15,811,474

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

     ☒

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     15.8%

    14  

     TYPE OF REPORTING PERSON

     

     HC and CO


    Page 5

    SCHEDULE 13D

    CUSIP No. 901164

     

     1   

     NAME OF REPORTING PERSONS

     

     Constellation Capital LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☒  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS

     

     OO

     5  

     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7    

     SOLE VOTING POWER

     

     0

        8   

     SHARED VOTING POWER

     

     15,811,474

        9   

     SOLE DISPOSITIVE POWER

     

     0

       10   

     SHARED DISPOSITIVE POWER

     

     15,811,474

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     15,811,474

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

     ☒

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     15.8%

    14  

     TYPE OF REPORTING PERSON

     

     HC and CO


    Page 6

    SCHEDULE 13D

    CUSIP No. 901164

     

     1   

     NAME OF REPORTING PERSONS

     

     Constellation International Holdings Limited

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☒  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS

     

     OO

     5  

     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     New York

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7    

     SOLE VOTING POWER

     

     0

        8   

     SHARED VOTING POWER

     

     15,811,474

        9   

     SOLE DISPOSITIVE POWER

     

     0

       10   

     SHARED DISPOSITIVE POWER

     

     15,811,474

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     15,811,474

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

     ☒

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     15.8%

    14  

     TYPE OF REPORTING PERSON

     

     HC and CO


    Page 7

    SCHEDULE 13D

    CUSIP No. 901164

     

     1   

     NAME OF REPORTING PERSONS

     

     CBG Holdings LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☒  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS

     

     OO

     5  

     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7    

     SOLE VOTING POWER

     

     0

        8   

     SHARED VOTING POWER

     

     10,450,000

        9   

     SOLE DISPOSITIVE POWER

     

     0

       10   

     SHARED DISPOSITIVE POWER

     

     10,450,000

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     10,450,000

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

     ☒

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     10.4%

    14  

     TYPE OF REPORTING PERSON

     

     CO


    Page 8

    SCHEDULE 13D

    CUSIP No. 901164

     

     1   

     NAME OF REPORTING PERSONS

     

     Greenstar II LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☒  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS

     

     OO

     5  

     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7    

     SOLE VOTING POWER

     

     0

        8   

     SHARED VOTING POWER

     

     10,450,000

        9   

     SOLE DISPOSITIVE POWER

     

     0

       10   

     SHARED DISPOSITIVE POWER

     

     10,450,000

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     10,450,000

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

     ☒

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     10.4%

    14  

     TYPE OF REPORTING PERSON

     

     HC and CO


    Page 9

    SCHEDULE 13D

    CUSIP No. 901164

     

     1   

     NAME OF REPORTING PERSONS

     

     Greenstar II Holdings LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☒  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS

     

     OO

     5  

     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7    

     SOLE VOTING POWER

     

     0

        8   

     SHARED VOTING POWER

     

     10,450,000

        9   

     SOLE DISPOSITIVE POWER

     

     0

       10   

     SHARED DISPOSITIVE POWER

     

     10,450,000

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     10,450,000

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

     ☒

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     10.4%

    14  

     TYPE OF REPORTING PERSON

     

     HC and CO


    Page 10

    SCHEDULE 13D

    CUSIP No. 901164

     

     1   

     NAME OF REPORTING PERSONS

     

     Constellation Brands, Inc.

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☒  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS

     

     OO

     5  

     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7    

     SOLE VOTING POWER

     

     0

        8   

     SHARED VOTING POWER

     

     26,261,474

        9   

     SOLE DISPOSITIVE POWER

     

     0

       10   

     SHARED DISPOSITIVE POWER

     

     26,261,474

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     26,261,474

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

     ☒

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     26.2%

    14  

     TYPE OF REPORTING PERSON

     

     HC and CO


    This Amendment No. 13 (this “Amendment”) is being filed by Greenstar Canada Investment Limited Partnership (“Greenstar LP”), Greenstar Canada Investment Corporation (“GCIC”), Constellation Brands Canada Holdings ULC, Constellation Capital LLC, Constellation International Holdings Limited (“CIHL”), CBG Holdings LLC (“CBG”), Greenstar II LLC (“GII”), Greenstar II Holdings LLC (“GIIH”), and Constellation Brands, Inc. (“Constellation”) (collectively, the “Reporting Persons”), pursuant to Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

    This Amendment amends the Schedule 13D filed on July 17, 2018 by Greenstar LP, GCIC, Constellation Brands Canada Holdings ULC, Constellation Capital LLC, CIHL and Constellation (the “Initial Schedule 13D”), as the Initial Schedule 13D was amended by (i) Amendment No. 1 filed on August 16, 2018 (the “First Amendment”), by the Reporting Persons (other than GII and GIIH); (ii) Amendment No. 2 filed on November 2, 2018 (the “Second Amendment”) by CBG and Constellation; (iii) Amendment No. 3 filed on December 3, 2018 (the “Third Amendment”) by the Reporting Persons (other than CBG, GII and GIIH); (iv) Amendment No. 4 filed on July 3, 2019 (the “Fourth Amendment”) by the Reporting Persons (other than GII and GIIH); (v) Amendment No. 5 filed on May 4, 2020 (the “Fifth Amendment”) by the Reporting Persons (other than CBG, GII and GIIH); (vi) Amendment No. 6 filed on April 29, 2021 (the “Sixth Amendment”) by the CBG, GII, GIIH and Constellation; (vii) Amendment No. 7 filed on July 1, 2022 (the “Seventh Amendment”) by the Reporting Persons (other than CBG, GII and GIIH); (viii) Amendment No. 8 filed on July 19, 2022 (the “Eighth Amendment”) by the Reporting Persons (other than CBG, GII and GIIH); (ix) Amendment No. 9 filed on October 26, 2022 (the “Ninth Amendment”) by the Reporting Persons; (x) Amendment No. 10 filed on April 17, 2023 (the “Tenth Amendment”) by the Reporting Persons; (xi) Amendment No. 11 filed on July 20, 2023 (the “Eleventh Amendment”) by the Reporting Persons; and (xii) Amendment No. 12 filed on November 3, 2023 (the “Twelfth Amendment,” and together with the First Amendment, the Second Amendment, the Third Amendment, the Fourth Amendment, the Fifth Amendment, the Sixth Amendment, the Seventh Amendment, the Eighth Amendment, the Ninth Amendment, the Tenth Amendment, the Eleventh Amendment, and the Initial Schedule 13D, the “Schedule 13D”) by the Reporting Persons.

    Item 1. Security and Issuer.

    Item 1 of the Schedule 13D is hereby amended and restated in its entirety with the following:

    The title and class of equity securities to which this Amendment relates are Common Shares, no par value (“Common Shares”), of Canopy Growth Corporation, a company organized and existing under the laws of Canada (the “Issuer” or “Canopy”). The principal executive offices of the Issuer are located at 1 Hershey Drive, Smiths Falls, Ontario Canada, K7A 0A8.

    Item 2. Identity and Background.

    Paragraphs (a) – (c) of Item 2 of the Schedule 13D are hereby revised and supplemented with the following:

    (a) – (c) Current information concerning the identity and background of each executive officer and director of CBG, GII, GIIH, GCIC, Constellation Brands Canada Holdings ULC, Constellation Capital LLC, CIHL and Constellation is set forth on Annex A (collectively, the “Covered Persons”), attached hereto and incorporated herein by reference.

    Paragraphs (d) – (e) of Item 2 of the Schedule 13D are hereby revised and supplemented with the following:

    (d) – (e) None of the Reporting Persons or, to the best knowledge of CBG and Greenstar LP, any of the Covered Persons has, during the past five years, been (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors), or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which he, she or it is or was subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

     

    Page 11


    Item 3. Source and Amount of Funds or Other Consideration.

    Item 3 of the Schedule 13D is hereby revised and supplemented with the following:

    As described below in Item 4, (i) CBG and Greenstar LP exchanged their Common Shares of the Issuer for non-voting and non-participating Exchangeable Shares (“Exchangeable Shares”) of the Issuer, and (ii) Greenstar LP exchanged approximately C$81.2 million of the principal amount of the Issuer’s C$100 million promissory note due 2024 (the “Note”) for Exchangeable Shares of the Issuer.

    Item 4. Purpose of Transaction.

    Item 4 of the Schedule 13D is hereby revised and supplemented with the following:

    On April 18, 2024, CBG and Greenstar LP exchanged their Common Shares of the Issuer for Exchangeable Shares on a one-for-one basis. The amendment to the Issuer’s share capital and the creation of Exchangeable Shares were authorized by the Issuer’s shareholders at a special meeting held on April 12, 2024. Greenstar LP also entered into an Exchange Agreement, dated April 18, 2024 (the “Exchange Agreement”), with Canopy, pursuant to which Greenstar LP agreed to exchange approximately C$81.2 million of the principal amount of the Note for Exchangeable Shares of Canopy. Pursuant to the Exchange Agreement, Greenstar LP forgave all accrued but unpaid interest on the Note together with the remaining principal amount of the Note. Pursuant to the terms of the Exchange Agreement, an aggregate of 9,111,549 Exchangeable Shares were issued to Greenstar LP on April 18, 2024, which was calculated based on a price per share of C$8.91.

    Pursuant to their terms, Exchangeable Shares are convertible into Common Shares on a one-for-one basis at any time at the election of the holder. Greenstar and CBG do not intend to convert any of their outstanding Exchangeable Shares for Common Shares or own any Common Shares, in each case until such time as the U.S. domestic sale of marijuana could not reasonably be expected to violate the Controlled Substances Act, the Civil Asset Forfeiture Reform Act (as it relates to violation of the Controlled Substances Act) and all related applicable anti-money laundering laws. For Schedule 13D reporting purposes, CBG and Greenstar LP will be deemed to beneficially own Common Shares issuable on conversion of Exchangeable Shares.

    All board nominees of Constellation resigned from the Issuer’s board of directors effective April 18, 2024.

    Except as previously disclosed in the Schedule 13D or set forth in this Amendment, the Reporting Persons have no present plans or proposals that relate to or would result in any of the actions described in Item 4(a) through (j) of Schedule 13D. The Reporting Persons may evaluate on a continuing basis their investment in the Issuer and expect that they may from time to time dispose of Exchangeable Shares or other securities of the Issuer, convert their Exchangeable Shares to Common Shares and purchase or sell Common Shares or other securities of the Issuer in the future, either on the open market or in private transactions, in each case, depending on a number of factors, including general market and economic and industry conditions and other available investment opportunities. Depending on market conditions, general economic and industry conditions, the Issuer’s business and financial condition and/or other relevant factors, the Reporting Persons may develop other plans or intentions in the future relating to one or more of the actions described in Item 4(a) through (j) of Schedule 13D.

    Item 5. Interest in Securities of the Issuer.

    Paragraphs (a) – (c) of Item 5 of the Schedule 13D are hereby revised and supplemented with the following:

    (a) – (c) Exchangeable Shares are convertible into Common Shares on a one-for-one basis at any time at the election of the holder. Each of the percentages of Common Shares beneficially owned indicated below and in the tables on pages 2 through 10 is calculated assuming the conversion of Exchangeable Shares into Common Shares.

     

    Page 12


    Greenstar LP has direct beneficial ownership of 15,811,474 Exchangeable Shares, representing approximately 15.8% of the issued and outstanding Common Shares of the Issuer as of April 18, 2024. GCIC is the general partner of Greenstar LP and is wholly-owned by Constellation Brands Canada Holdings ULC, which in turn is wholly-owned by Constellation Capital LLC, which in turn is wholly-owned by CIHL, which in turn is wholly-owned by Constellation.

    CBG has direct beneficial ownership of 10,450,000 Exchangeable Shares of the Issuer, representing approximately 10.4% of the issued and outstanding Common Shares of the Issuer as of April 18, 2024. CBG is wholly-owned by GII, which in turn is wholly-owned by GIIH, which in turn is wholly-owned by Constellation.

    In the aggregate, Constellation has indirect beneficial ownership of 26,261,474 Exchangeable Shares of the Issuer, representing approximately 26.2% of the issued and outstanding Common Shares of the Issuer as of April 18, 2024.

    Except as set forth in the Schedule 13D, to the best knowledge of the Reporting Persons and other than as previously disclosed, the Covered Persons do not beneficially own any Common Shares or Exchangeable Shares as of April 18, 2024, other than Judy A. Schmeling, who holds 32,009 Common Shares which were acquired following the vesting of restricted stock units acquired as compensation for her position as a director of the Issuer and restricted stock units convertible into 10,044 Common Shares, which were acquired on August 22, 2023 as compensation for her position as a director of the Issuer. The Reporting Persons disclaim beneficial ownership of each Covered Person’s Common Shares and Exchangeable Shares and such Common Shares and Exchangeable Shares are excluded from the aggregate amounts reported by the Reporting Persons in this Amendment and Schedule 13D.

    Except as set forth herein, neither the Reporting Persons, nor to the best knowledge of the Reporting Persons, any of the Covered Persons, has engaged in any transaction involving any Common Shares or Exchangeable Shares in the 60-day period ended April 18, 2024.

    The aggregate percentage of Common Shares reported owned by the Reporting Persons is based upon 100,217,939 Common Shares outstanding (assuming the conversion of all Exchangeable Shares outstanding into Common Shares), which is the sum of the total number of Common Shares and Exchangeable Shares outstanding as of April 18, 2024, as provided to the Reporting Persons by the Issuer. All amounts of Common Shares reported by the Reporting Persons in this Amendment reflect the reverse stock split completed by the Issuer in December 2023.

    Item 6. Contracts, Arrangements, Understandings, or Relationships to Securities of the Issuer.

    Item 6 of the Schedule 13D is hereby revised and supplemented with the following:

    In connection with the exchange described in Item 4 above, CBG, Greenstar LP, and the Issuer have terminated the investor rights agreement, administrative services agreement, co-development agreement, and all other commercial arrangements between them and their subsidiaries, other than the consent agreement pursuant to which CBG and Greenstar LP consented to the amendment to the Issuer’s share capital, certain termination agreements, and the Exchange Agreement. The form of termination agreements were filed with Exhibit 99.1 to the Ninth Amendment.

    As a result, CBG and Greenstar LP have no further governance rights in relation to the Issuer, including rights to nominate members to the Board of Directors of the Issuer, or approval or consulting rights related to certain transactions. All board nominees of Constellation resigned from the Issuer’s Board of Directors effective April 18, 2024.

    As described above in Item 4, which is incorporated herein by reference, Greenstar LP entered into the Exchange Agreement.

    Other than as described in this Amendment and the Schedule 13D, there are no contracts, arrangements, understandings, or relationships (legal or otherwise) between the Reporting Persons and any other person with respect to any securities, including Common Shares.

     

    Page 13


    Item 7. Material to Be Filed as Exhibits.

     

    Exhibit 99.1    Notice of Conversion of Common Shares by Greenstar Canada Investment Limited Partnership.
    Exhibit 99.2    Notice of Conversion of Common Shares by CBG Holdings LLC.
    Exhibit 99.3    Exchange Agreement, dated April 18, 2024, between Greenstar Canada Investment Limited Partnership and Canopy Growth Corporation.
    Exhibit 99.4    Joint Filing Agreement among the Reporting Persons dated April 19, 2024.

     

    Page 14


    Signature

    After reasonable inquiry and to the best of the undersigned’s knowledge and belief I certify that the information set forth in this statement is true, complete, and correct.

     

    Dated: April 19, 2024     CBG Holdings LLC
        By:  

    /s/ Kenneth W. Metz

        Name:   Kenneth W. Metz
        Title:   President
        Greenstar II LLC
        By:  

    /s/ Oksana S. Dominach

        Name:   Oksana S. Dominach
        Title:   Vice President and Treasurer
        Greenstar II Holdings LLC
        By:  

    /s/ Oksana S. Dominach

        Name:   Oksana S. Dominach
        Title:   Vice President and Treasurer
        Greenstar Canada Investment Limited Partnership
        By:   Greenstar Canada Investment Corporation, its
          general partner
        By:  

    /s/ Kenneth W. Metz

        Name:   Kenneth W. Metz
        Title:   President
        Greenstar Canada Investment Corporation
        By:  

    /s/ Kenneth W. Metz

        Name:   Kenneth W. Metz
        Title:   President
        Constellation Brands Canada Holdings ULC
        By:  

    /s/ Kenneth W. Metz

        Name:   Kenneth W. Metz
        Title:   President
        Constellation Capital LLC
        By:  

    /s/ Oksana S. Dominach

        Name:   Oksana S. Dominach
        Title:   Vice President and Treasurer


      Constellation International Holdings Limited
      By:  

    /s/ Oksana S. Dominach

      Name:   Oksana S. Dominach
      Title:   Vice President and Treasurer
      Constellation Brands, Inc.
      By:  

    /s/ James O. Bourdeau

      Name:   James O. Bourdeau
      Title:   Executive Vice President, Chief Legal Officer
        and Secretary


    Annex A

    The following is a list, as of April 18, 2024, of the executive officers and directors of each of CBG Holdings LLC, Greenstar II LLC, Greenstar II Holdings LLC, Greenstar Canada Investment Corporation, Constellation Brands Canada Holdings ULC, Constellation Capital LLC, Constellation International Holdings Limited and Constellation Brands, Inc. (collectively, the “Covered Persons”), setting forth the present principal occupation or employment and the name, principal business and address of any corporation or other organization in which such employment is conducted and citizenship for each such person. Each Covered Person is a citizen of the United States, unless otherwise noted, and does not have any other principal occupation (outside of similar positions held with respect to other entities directly or indirectly affiliated with Constellation Brands, Inc.) unless otherwise noted.

    Executive Officers of CBG Holdings LLC:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    Kenneth W. Metz    President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Becka    Vice President    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Oksana S. Dominach    Vice President and Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Jeffrey H. LaBarge    Vice President and Assistant Secretary    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Reitz    Vice President and Assistant Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Timothy D. Robins    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Brian S. Bennett    Secretary    207 High Point Drive, Building 100, Victor, New York 14564    US

    Directors of CBG Holdings LLC:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    James O. Bourdeau    Executive Vice President, Chief Legal Officer and Secretary of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US

    Executive Officers of Greenstar II LLC:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    Garth Hankinson    President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Becka    Vice President    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Oksana S. Dominach    Vice President and Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Jeffrey H. LaBarge    Vice President and Assistant Secretary    207 High Point Drive, Building 100, Victor, New York 14564    US
    Kenneth W. Metz    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Reitz    Vice President and Assistant Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Timothy D. Robins    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Brian S. Bennett    Secretary    207 High Point Drive, Building 100, Victor, New York 14564    US


    Directors of Greenstar II LLC:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    James O. Bourdeau    Executive Vice President, Chief Legal Officer and Secretary of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Garth Hankinson    Executive Vice President and Chief Financial Officer of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Oksana S. Dominach    Senior Vice President of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US

    Executive Officers of Greenstar II Holdings LLC:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    Garth Hankinson    President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Becka    Vice President    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Oksana S. Dominach    Vice President and Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Jeffrey H. LaBarge    Vice President and Assistant Secretary    207 High Point Drive, Building 100, Victor, New York 14564    US
    Kenneth W. Metz    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Reitz    Vice President and Assistant Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Timothy D. Robins    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Brian S. Bennett    Secretary    207 High Point Drive, Building 100, Victor, New York 14564    US

    Directors of Greenstar II Holdings LLC:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    James O. Bourdeau    Executive Vice President, Chief Legal Officer and Secretary of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Garth Hankinson    Executive Vice President and Chief Financial Officer of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Oksana S. Dominach    Senior Vice President of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US


    Executive Officers of Greenstar Canada Investment Corporation:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    Kenneth W. Metz    President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Oksana S. Dominach    Vice President and Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Timothy D. Robins    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Brian S. Bennett    Secretary    207 High Point Drive, Building 100, Victor, New York 14564    US

    Directors of Greenstar Canada Investment Corporation:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    James O. Bourdeau    Executive Vice President, Chief Legal Officer and Secretary of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Oksana S. Dominach    Senior Vice President of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Kenneth W. Metz    Senior Vice President, Finance, Wine & Spirits Division of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US

    Executive Officers of Constellation Brands Canada Holdings ULC:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    Kenneth W. Metz    President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Oksana S. Dominach    Vice President and Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Timothy D. Robins    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Brian S. Bennett    Secretary    207 High Point Drive, Building 100, Victor, New York 14564    US


    Directors of Constellation Brands Canada Holdings ULC:

     

    Name

      

    Principal Occupation or Employment

      

    Business Address

      

    Citizenship

    Oksana S. Dominach    Senior Vice President of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Timothy D. Robins    Vice President, Tax of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US

    Executive Officers of Constellation Capital LLC:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    Garth Hankinson    President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Becka    Vice President    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Oksana S. Dominach    Vice President and Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Kenneth W. Metz    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Reitz    Vice President and Assistant Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Timothy D. Robins    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Brian S. Bennett    Secretary    207 High Point Drive, Building 100, Victor, New York 14564    US

    Directors of Constellation Capital LLC:

     

    Name

      

    Principal Occupation or Employment

      

    Business Address

      

    Citizenship

    James O. Bourdeau    Executive Vice President, Chief Legal Officer and Secretary of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Oksana S. Dominach    Senior Vice President of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US


    Executive Officers of Constellation International Holdings Limited:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    James A. Sabia, Jr.    President    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Garth Hankinson    Executive Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Becka    Vice President    131 S. Dearborn Street, Chicago, Illinois 60603    US

     

    Oksana S. Dominach    Vice President and Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Kenneth W. Metz    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Reitz    Vice President and Assistant Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Timothy D. Robins    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Brian S. Bennett    Secretary    207 High Point Drive, Building 100, Victor, New York 14564    US

    Directors of Constellation International Holdings Limited:

     

    Name

      

    Principal Occupation or Employment

      

    Business Address

      

    Citizenship

    James O. Bourdeau    Executive Vice President, Chief Legal Officer and Secretary of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Oksana S. Dominach    Senior Vice President of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    James A. Sabia, Jr.    Executive Vice President and President, Beer Division of Constellation Brands, Inc.    131 S. Dearborn Street, Chicago, Illinois 60603    US

    Executive Officers of Constellation Brands, Inc.:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    William A. Newlands    President and Chief Executive Officer    131 S. Dearborn Street, Chicago, Illinois 60603    US
    James O. Bourdeau    Executive Vice President, Chief Legal Officer and Secretary    207 High Point Drive, Building 100, Victor, New York 14564    US
    K. Kristann Carey    Executive Vice President and Chief Human Resources Officer    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Samuel J. Glaetzer    Executive Vice President and President, Wine and Spirits Division    101 Mission Street, San Francisco, California 94105    US
    Garth Hankinson    Executive Vice President and Chief Financial Officer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael McGrew    Executive Vice President and Chief Communications, Strategy, ESG and Diversity Officer    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Mallika Monteiro    Executive Vice President and Chief Growth and Digital Officer and Managing Director, Beer Brands    131 S. Dearborn Street, Chicago, Illinois 60603    US
    James A. Sabia, Jr.    Executive Vice President and President, Beer Division    131 S. Dearborn Street, Chicago, Illinois 60603    US


    Directors of Constellation Brands, Inc.:

     

    Name

      

    Principal Occupation or Employment

      

    Business Address

      

    Citizenship

    Christopher J. Baldwin    Managing Partner, CVC Advisors (U.S.) Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Christy Clark    Senior Advisor, Bennett Jones LLP    207 High Point Drive, Building 100, Victor, New York 14564    Canada
    Jennifer M. Daniels    Chief Legal Officer and Secretary of Colgate-Palmolive Company    207 High Point Drive, Building 100, Victor, New York 14564    US
    Nicholas I. Fink    Chief Executive Officer of Fortune Brands Innovations, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    William T. Giles    Former Chief Financial Officer and Executive Vice President of AutoZone, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Ernesto M. Hernández    Former President and Managing Director of General Motors de Mexico, S. de R.L. de C.V.    207 High Point Drive, Building 100, Victor, New York 14564    Mexico
    José Manuel Madero Garza    Independent Business Consultant and Former Chief Executive Officer of Grupo Bepensa; Interim Chair of the Board of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    Mexico
    Daniel J. McCarthy    Former President and Chief Executive Officer of Frontier Communications Corporation    207 High Point Drive, Building 100, Victor, New York 14564    US
    William A. Newlands    President and Chief Executive Officer of Constellation Brands, Inc.    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Richard Sands    Non-Management Director of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Robert Sands    Non-Management Director of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Judy A. Schmeling    Former Chief Operating Officer of HSN, Inc., and former President of HSN’s Cornerstone Brands    207 High Point Drive, Building 100, Victor, New York 14564    US
    Luca Zaramella    Executive Vice President, Chief Financial Officer of Mondelēz International    207 High Point Drive, Building 100, Victor, New York 14564    Italy
    Get the next $CGC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CGC

    DatePrice TargetRatingAnalyst
    4/4/2023Underperform → Mkt Perform
    Bernstein
    11/2/2022$1.50Underperform
    Bernstein
    10/26/2022Sell → Hold
    Canaccord Genuity
    6/8/2022Market Perform → Underperform
    BMO Capital Markets
    3/22/2022Equal Weight → Underweight
    Barclays
    3/1/2022$14.00 → $9.00Equal-Weight
    Barclays
    2/18/2022$9.60 → $11.00Neutral
    Cantor Fitzgerald
    12/22/2021Neutral → Underperform
    BofA Securities
    More analyst ratings

    $CGC
    Leadership Updates

    Live Leadership Updates

    See more
    • Canopy USA Announces Appointment of Mr. M. Brooks Jorgensen as President

      A cannabis and beverage alcohol industry executive with more than 25 years of experience, Mr. Jorgensen will lead the unified Canopy USA organization forward with a focus on driving profitable growth across the U.S. With the completed acquisitions of Acreage, Wana, and Jetty, Canopy USA now enters a new chapter of growth across key segments including flower, edibles, vapes, extracts, and through an established retail presence in high potential markets across the Midwest and Northeast BOULDER, Colo., January 6, 2025 /PRNewswire/ - Canopy USA, LLC ("Canopy USA"), a brand-driven organization strategically positioned across the fastest growing states and highest potential segments of the U.S. c

      1/6/25 7:30:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth Announces Results of Annual General Meeting

      SMITHS FALLS, ON, Sept. 25, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) is pleased to announce today the voting results from its annual general meeting of shareholders held on September 24, 2024 (the "Meeting"). All of the matters put forward before the Company's shareholders for consideration and approval, as set out in the Company's definitive proxy statement dated August 1, 2024 (the "Proxy Statement"), were approved by the requisite number of votes cast at the Meeting, as further detailed below. Each of the direc

      9/25/24 7:30:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth Announces Extension of Proxy Voting Deadline for Upcoming Annual General Meeting

      Shareholders now have until September 24, 2024 at 9:00 a.m. (Eastern Time) to submit votes to help ensure a quorum is achieved Your Vote is Important! If you need assistance with voting your shares please contact Laurel Hill Advisory Group at 1-877-452-7184 or by e-mail at [email protected] SMITHS FALLS, ON, Sept. 20, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) announced today that it has extended the deadline for the submission of proxies related to its upcoming annual general meeting of shareholders (the "Meeting") to September 24, 2024 at 9:00 a.m. (Eastern time). The Meeting will be held later the same day, at 1:00 p.m.

      9/20/24 4:45:00 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care

    $CGC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Canopy Growth to Report Fourth Quarter and Fiscal Year 2025 Financial Results on May 30, 2025

      Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED, NASDAQ:CGC) will release its financial results for the fourth quarter and fiscal year 2025 ended March 31, 2025, before financial markets open on May 30, 2025. Following the release of its fourth quarter and fiscal year 2025 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and Judy Hong, CFO on May 30, 2025, at 10 AM Eastern Time (ET). Webcast Information A live audio webcast will be available at: https://onlinexperiences.com/Launch/QReg/ShowUUID=1235414F-AB39-4A0B-871E-B1885B487ACD Replay Information A replay will be accessible by webcast until 11:59 PM ET on August 28, 2025 at:

      5/16/25 7:30:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth Drives Innovation in High-Demand Segments With Latest Product Launches

      Offerings reflect a focused format strategy in Canada's adult-use market Vapes, high-THC flower, pre-roll joints, and edibles introduced across core brands Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has launched a series of product innovations targeting Canada's fastest-growing adult-use categories.1 The lineup reflects a focused strategy built around four high-demand formats: vapes, high-THC flower, pre-rolls (including infused), and edibles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20

      5/6/25 7:30:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth and Spectrum Therapeutics Announce Spectrum Reserve, A New Premium Medical Cannabis Brand

      New Brand Features Premium Genetics, Selected for Potency, Terpenes, and Consistency Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has launched Spectrum Reserve, a new premium medical cannabis brand in Canada. Designed to meet the evolving needs of medical cannabis patients, Spectrum Reserve represents the peak of cannabis cultivation – featuring flower selected for size, potency, and terpene levels through rigorous in-house standards during cultivation and post-harvest. Under this new program, Spectrum Reserve is expected to introduce new strains on a r

      4/2/25 7:30:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care

    $CGC
    Financials

    Live finance-specific insights

    See more
    • Canopy Growth to Report Fourth Quarter and Fiscal Year 2025 Financial Results on May 30, 2025

      Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED, NASDAQ:CGC) will release its financial results for the fourth quarter and fiscal year 2025 ended March 31, 2025, before financial markets open on May 30, 2025. Following the release of its fourth quarter and fiscal year 2025 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and Judy Hong, CFO on May 30, 2025, at 10 AM Eastern Time (ET). Webcast Information A live audio webcast will be available at: https://onlinexperiences.com/Launch/QReg/ShowUUID=1235414F-AB39-4A0B-871E-B1885B487ACD Replay Information A replay will be accessible by webcast until 11:59 PM ET on August 28, 2025 at:

      5/16/25 7:30:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • The Week in Canadian Press Releases: 10 Stories You Need to See

      A roundup of the most newsworthy press releases from Cision Distribution this week TORONTO, Feb. 14, 2025 /CNW/ - With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that

      2/14/25 6:18:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth Reports Third Quarter Fiscal Year 2025 Financial Results

      Strong holiday sales drove Storz & Bickel net revenue growth of 19% year-over-year   Record quarter for Canada medical cannabis with net revenue increasing 16%; international markets cannabis net revenue grew 14% year-over-year    Successfully launched Claybourne infused pre-rolls across Canada, Claybourne rose to #3 market share in the infused pre-roll category in British Columbia and Ontario after 6 weeks in market1 SMITHS FALLS, ON, Feb. 7, 2025 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announces its financial results for the third fiscal quarter ended December 31, 2024 ("Q3 FY2025"). All financial information in this press

      2/7/25 7:00:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care

    $CGC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Canopy Growth upgraded by Bernstein

      Bernstein upgraded Canopy Growth from Underperform to Mkt Perform

      4/4/23 9:09:41 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Bernstein initiated coverage on Canopy Growth with a new price target

      Bernstein initiated coverage of Canopy Growth with a rating of Underperform and set a new price target of $1.50

      11/2/22 6:11:10 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth upgraded by Canaccord Genuity

      Canaccord Genuity upgraded Canopy Growth from Sell to Hold

      10/26/22 7:36:52 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care

    $CGC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Yanofsky Theresa sold $1,844 worth of shares (2,004 units at $0.92), decreasing direct ownership by 9% to 20,199 units (SEC Form 4)

      4 - Canopy Growth Corp (0001737927) (Issuer)

      4/2/25 4:17:13 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Lazzarato David Angelo sold $2,764 worth of shares (3,004 units at $0.92), decreasing direct ownership by 12% to 22,886 units (SEC Form 4)

      4 - Canopy Growth Corp (0001737927) (Issuer)

      4/2/25 4:16:37 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Kruh Willy sold $1,851 worth of shares (2,012 units at $0.92), decreasing direct ownership by 18% to 9,272 units (SEC Form 4)

      4 - Canopy Growth Corp (0001737927) (Issuer)

      4/2/25 4:15:15 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care

    $CGC
    SEC Filings

    See more
    • Canopy Growth Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Canopy Growth Corp (0001737927) (Filer)

      4/1/25 7:54:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Canopy Growth Corp (0001737927) (Filer)

      2/28/25 5:19:22 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 424B5 filed by Canopy Growth Corporation

      424B5 - Canopy Growth Corp (0001737927) (Filer)

      2/28/25 5:17:50 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care

    $CGC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Canopy Growth Corporation (Amendment)

      SC 13D/A - Canopy Growth Corp (0001737927) (Subject)

      4/19/24 5:00:49 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D/A filed by Canopy Growth Corporation (Amendment)

      SC 13D/A - Canopy Growth Corp (0001737927) (Subject)

      11/3/23 4:30:53 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D/A filed by Canopy Growth Corporation (Amendment)

      SC 13D/A - Canopy Growth Corp (0001737927) (Subject)

      7/20/23 4:35:52 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care